{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:37:58Z","timestamp":1768437478633,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK089507"],"award-info":[{"award-number":["P30 DK089507"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jcf.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T09:22:04Z","timestamp":1676539324000},"page":"864-867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations"],"prefix":"10.1016","volume":"22","author":[{"given":"Sonya L.","family":"Heltshe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0867-8516","authenticated-orcid":false,"given":"Renee","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5727-8164","authenticated-orcid":false,"given":"Donald R.","family":"VanDevanter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don B.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2023.02.006_bib0001","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jpeds.2005.10.019","article-title":"Cystic fibrosis pulmonary exacerbations","volume":"148","author":"Ferkol","year":"2006","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.jcf.2023.02.006_bib0002","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/thx.2006.060889","article-title":"Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis","volume":"62","author":"Goss","year":"2007","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jcf.2023.02.006_bib0003","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1378\/chest.121.1.64","article-title":"Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis","volume":"121","author":"Britto","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jcf.2023.02.006_bib0004","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.jcf.2023.02.006_bib0005","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1542\/peds.103.6.e72","article-title":"The cost of medical care for patients with cystic fibrosis in a health maintenance organization","volume":"103","author":"Lieu","year":"1999","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jcf.2023.02.006_bib0006","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ppul.20023","article-title":"Epidemiologic study of cystic fibrosis. Pulmonary exacerbations in cystic fibrosis","volume":"37","author":"Rabin","year":"2004","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jcf.2023.02.006_bib0007","series-title":"Treatment of Pulmonary Exacerbation of Cystic Fibrosis. Clinical Practice Guidelines for Cystic Fibrosis","year":"1997"},{"issue":"9","key":"10.1016\/j.jcf.2023.02.006_bib0008","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.jcf.2023.02.006_bib0009","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/ppul.24577","article-title":"Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis","volume":"55","author":"Wagener","year":"2020","journal-title":"Pediatr. Pulmonol."},{"issue":"10","key":"10.1016\/j.jcf.2023.02.006_bib0010","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/ppul.23765","article-title":"Poor recovery from cystic fibrosis pulmonary exacerbations is associated with poor long-term outcomes","volume":"52","author":"Sanders","year":"2017","journal-title":"Pediatr. Pulmonol."},{"issue":"9","key":"10.1016\/j.jcf.2023.02.006_bib0011","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1164\/rccm.201001-0057OC","article-title":"Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes","volume":"182","author":"Collaco","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.jcf.2023.02.006_bib0012","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"Sanders","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.jcf.2023.02.006_bib0013","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jcf.2015.01.007","article-title":"Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients","volume":"14","author":"Waters","year":"2015","journal-title":"J. Cyst. Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2023.02.006_bib0014","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","article-title":"The cystic fibrosis foundation patient registry: design and methods of a national observational disease registry","volume":"13","author":"Knapp","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"6","key":"10.1016\/j.jcf.2023.02.006_bib0015","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jcf.2023.02.006_bib0016","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group","volume":"340","author":"Ramsey","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcf.2023.02.006_bib0017","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1378\/chest.08-1421","article-title":"Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis","volume":"135","author":"Retsch-Bogart","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jcf.2023.02.006_bib0018","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ppul.21350","article-title":"Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection","volume":"46","author":"Moskowitz","year":"2011","journal-title":"Pediatr. Pulmonol."},{"issue":"5","key":"10.1016\/j.jcf.2023.02.006_bib0019","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcf.2017.04.004","article-title":"Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis","volume":"16","author":"VanDevanter","year":"2017","journal-title":"J. Cyst. Fibros."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:07:32Z","timestamp":1762553252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1569199323000553"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.02.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}